Process for isolating nucleated cells and nucleated cell populations and uses thereof
AssigneeMesotex, Inc.
InventorGiammaria SITAR
Life of this patent
Estimating the term…
Abstract
The present disclosure provides processes for isolating target nucleated cells, such as fetal mesenchymal stem cells, from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and methods of using isolated targeted nucleated cells methods and their progeny for detecting fetal abnormalities and stem cell therapy.
Claims30
A process for isolating a population of target nucleated cells from non-nucleated red blood cells present in a blood derived nucleated cell enriched fraction containing no more than 20% of the non-nucleated red blood cells from the blood, comprising subjecting the nucleated cell enriched fraction to at least one of:
- a) negative selection for the target nucleated cells;
- b) positive selection for the target nucleated cells;
- and
- c) density gradient centrifugation,
- thereby isolating a population of target nucleated cells.
Dependencies are inferred from the claim text.